- Home
- VNDA vs FLIC Comparison
VNDA vs FLIC Comparison
Compare VNDA & FLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- FLIC
- Stock Information
- Founded
- VNDA 2002
- FLIC 1927
- Country
- VNDA United States
- FLIC United States
- Employees
- VNDA N/A
- FLIC N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- FLIC Major Banks
- Sector
- VNDA Health Care
- FLIC Finance
- Exchange
- VNDA Nasdaq
- FLIC Nasdaq
- Market Cap
- VNDA 257.8M
- FLIC 275.5M
- IPO Year
- VNDA 2006
- FLIC N/A
- Fundamental
- Price
- VNDA $4.43
- FLIC $12.96
- Analyst Decision
- VNDA Strong Buy
- FLIC Hold
- Analyst Count
- VNDA 2
- FLIC 1
- Target Price
- VNDA $16.50
- FLIC $13.00
- AVG Volume (30 Days)
- VNDA 640.7K
- FLIC 96.1K
- Earning Date
- VNDA 02-13-2025
- FLIC 01-30-2025
- Dividend Yield
- VNDA N/A
- FLIC 6.32%
- EPS Growth
- VNDA N/A
- FLIC N/A
- EPS
- VNDA N/A
- FLIC 0.75
- Revenue
- VNDA $198,772,000.00
- FLIC $84,928,000.00
- Revenue This Year
- VNDA $16.07
- FLIC N/A
- Revenue Next Year
- VNDA $24.42
- FLIC N/A
- P/E Ratio
- VNDA N/A
- FLIC $17.73
- Revenue Growth
- VNDA 3.18
- FLIC N/A
- 52 Week Low
- VNDA $3.71
- FLIC $9.30
- 52 Week High
- VNDA $6.75
- FLIC $15.03
- Technical
- Relative Strength Index (RSI)
- VNDA 44.53
- FLIC 47.48
- Support Level
- VNDA $4.34
- FLIC $13.57
- Resistance Level
- VNDA $4.65
- FLIC $14.00
- Average True Range (ATR)
- VNDA 0.21
- FLIC 0.47
- MACD
- VNDA -0.01
- FLIC -0.05
- Stochastic Oscillator
- VNDA 36.51
- FLIC 32.04
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About FLIC First of Long Island Corporation (The)
First of Long Island Corp is a holding company that provides financial services. It offers services of saving accounts, current accounts, and capital gain accounts. The company also provides lending services, such as commercial and residential mortgage loans, industrial loans, small business credit scored loans, and other credit facilities. In addition, the company provides account reconciliation services, ATM Banking, bill payment, cash management services, mobile banking, online banking, and payroll services to privately owned businesses, professionals, consumers, and public bodies. Revenue earned by the company mainly consists of the interest on loans and investment securities, fees on deposit accounts, and income from investment management.